top of page
  • Zdjęcie autoraIMol

New study from our scientists in EMBO Reports!

The research reveals how targeting protein phosphatases can enhance efficiency of immunotherapy by affecting the spliceosome. Collaborating with Prof. Rene Bernards' group at Antoni van Leeuwenhoek, Dr. Vladyslava Liudkovska and Dr. Maciej Cieśla from Mol raise a prospect of combining splicing targeting approaches with inhibition of phosphatases PP2A/PP5 in colon cancer.

Congratulations to Maciej, Vlada and co!





5 wyświetleń

Ostatnie posty

Zobacz wszystkie

Comments


bottom of page